Search results for

In a special feature to celebrate International Women’s Day on March 8, Ellie Mertens speaks to counsel at Uber, Xerox, Micron and others about women in IP – the progress and the path

China and Hong Kong have signed an agreement that allows the jurisdictions to mutually recognise one another’s IP judgments. George Chan, Vera Zuo, Wenyi Liu and Joy Shi of Simmons & Simmons provide an overview of the changes and how they will benefit IP owners

Since the first marketing authorisation for a monoclonal antibody (Mab) in the 1980s, the patent system has never stopped adding the fuel of interest to the fire of Mabs ingenuity.

Christian Liedtke of Acuminis examines the possibly far-reaching changes to US trademark practice rules seeking to abolish the ability of foreign trademark holders to represent themselves in trademark matters before the USPTO and its Trademark Trial and Appeal Board

The Australian government subsidises access to approved drugs via the Pharmaceutical Benefits Scheme (PBS). Under the scheme, the majority of the approved drug's cost is borne by the government in order to improve patient access.

It is quite encouraging for law practitioners in Greece that Greek IP specialised courts have managed to align national case law with EU case law on trademarks during the last decade, providing a tool for legal certainty.

Two issues have arisen recently causing the Technical Boards of Appeal to refer questions to the Enlarged Board of Appeal (EBA).

The US Federal Circuit has imposed restrictions on who can appeal against an inter partes review decision, making life difficult for some petitioners. However, there are some practical tips to consider, as Rose Cordero Prey and Eric Ding of Greenberg Traurig explain

In this increasingly transparent and closely connected world, trade secrets are becoming an effective way to protect certain intellectual assets. It is widely recognised that trade secrets can help a company maintain its competitive edge. Customer lists are often among a company's most valuable assets. Safeguarding this information may be critical to the success of a company. It is taken for granted that customer lists are treated as trade secrets which are protected by law. However, in reality, this is not always true. In China, a customer list must satisfy certain criteria in order to be considered a trade secret and thus entitled to legal protection.

One feature of Taiwan's Patent Law (and all the country's IP laws) that many patentees find interesting is the lack of indirect infringement. To seek remedies against suppliers (mainly contract manufacturers, or CMs) of essential elements of a patented invention, patentees need resort to the Civil Code rules regarding the liabilities for assisting torts.